Aerie Pharmaceuticals Inc
AERI
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$16.05
5.3% upside
Current Fair Value
5.3% upsideUndervalued by 5.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $140.12 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.61 |
| Beta | -0.06 |
| Outstanding Shares | 47,819,936 |
Return
| Return on Equity | 22.29% |
|---|---|
| Return on Assets | -9.73% |
| Return on Invested Capital | -11.03% |
Valuation & Multiples
| P/E Ratio | -9.45 |
|---|---|
| PEG | 29.14 |
| Price to Sales | 3.81 |
| Price to Book Ratio | -3.81 |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | -5.25 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 2.23 |
| Debt to Equity | -1.91 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aerie Pharmaceuticals Inc
CEO: Vicente Anido